Diversified Trust Co boosted its stake in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 8.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,575 shares of the company’s stock after buying an additional 650 shares during the period. Diversified Trust Co’s holdings in Prestige Consumer Healthcare were worth $272,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently made changes to their positions in PBH. Financial Gravity Wealth Inc. bought a new stake in Prestige Consumer Healthcare during the first quarter worth approximately $50,000. Quadrant Capital Group LLC lifted its holdings in shares of Prestige Consumer Healthcare by 2,979.3% during the first quarter. Quadrant Capital Group LLC now owns 1,786 shares of the company’s stock worth $53,000 after buying an additional 1,728 shares during the last quarter. Bailard Inc. acquired a new position in shares of Prestige Consumer Healthcare in the first quarter valued at $245,000. Citigroup Inc. raised its stake in shares of Prestige Consumer Healthcare by 72.2% in the fourth quarter. Citigroup Inc. now owns 9,271 shares of the company’s stock valued at $286,000 after purchasing an additional 3,887 shares in the last quarter. Finally, Foundry Partners LLC acquired a new position in shares of Prestige Consumer Healthcare in the first quarter valued at $289,000.
A number of brokerages recently commented on PBH. CIBC restated a “hold” rating and issued a $84.00 target price on shares of Prestige Consumer Healthcare in a research note on Monday, May 27th. ValuEngine upgraded Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a report on Friday, July 26th. Zacks Investment Research raised Prestige Consumer Healthcare from a “sell” rating to a “hold” rating and set a $31.00 target price on the stock in a research note on Tuesday, May 28th. Finally, TheStreet raised Prestige Consumer Healthcare from a “d+” rating to a “c-” rating in a research note on Tuesday, July 23rd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $61.07.
NYSE PBH opened at $33.97 on Friday. The firm has a market capitalization of $1.67 billion, a price-to-earnings ratio of 12.22, a P/E/G ratio of 1.78 and a beta of 0.91. The company has a debt-to-equity ratio of 1.63, a quick ratio of 1.26 and a current ratio of 2.16. The stock’s 50-day simple moving average is $32.17. Prestige Consumer Healthcare Inc has a one year low of $26.25 and a one year high of $41.76.
Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday,…